Clinical Trial 56425

Menifee, CA 92586



2021-PT055: Phase II, Double-Blind, Placebo-Controlled, Randomized Trial Examining Natrunix in Combination with Methotrexate for the Treatment of Rheumatoid Arthritis


-pts 18+

-must be MTX-inadequate responders

-has > or = 6/68 swollen/tender joints

-must be receiving 15-25 mg MTX/week for a minimum of 4 weeks


-any prior exposure to Natrunix

-no biologics within 8 weeks prior to randomization

-no JAKi within 4 weeks prior to randomization

-any concurrent autoimmune disease with the exception of Sjogren’s secondary to RA


Qualified Participants May Receive:

  • Study treatment at no charge
  • Diagnostic tests at no charge
  • Study related medical care
  • Compensation up to $900 for time and travel purposes

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.